PLEASANTON, Calif., Dec. 23, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference.
Related Articles

News
10x Genomics to Report First Quarter Financial Results on May 11, 2020
April 25, 2020
San Francisco Biotechnology Network News
News
Comments Off on 10x Genomics to Report First Quarter Financial Results on May 11, 2020
PLEASANTON, Calif., April 24, 2020 (GLOBE NEWSWIRE) — 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the first quarter 2020 after market close on Monday, May 11, 2020. The company?s management will webcast a correspo… […]

News
10x Genomics Reports First Quarter 2020 Financial Results
May 11, 2020
San Francisco Biotechnology Network News
News
Comments Off on 10x Genomics Reports First Quarter 2020 Financial Results
PLEASANTON, Calif., May 11, 2020 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the quarter ended March 31, 2020. […]

News
10x Genomics to Report Fourth Quarter and Full Year 2019 Financial Results on February 18, 2020
February 5, 2020
San Francisco Biotechnology Network News
News
Comments Off on 10x Genomics to Report Fourth Quarter and Full Year 2019 Financial Results on February 18, 2020
PLEASANTON, Calif., Feb. 04, 2020 (GLOBE NEWSWIRE) — 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2019 after market close on Tuesday, February 18, 2020. Company m… […]